Atlas Trials

IBSA Farmaceutici Italia Srl

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch IBSA Farmaceutici Italia Srl

RecordFirmDate
Safety and Efficacy Evaluation of Sodium Hyaluronate 32mg/ml in Improving Facial Skin Dryness and Dullness (NCT06914583)IBSA Farmaceutici Italia Srl2025-02-19
Evaluation of the Effects of Two Dietary Supplement Formulations on the Lipid Profile in Mild Hypercholesterolemia (NCT06810466)IBSA Farmaceutici Italia Srl2024-12-17
Evaluation of the Safety and Efficacy of Profhilo® Structura (NCT06719154)IBSA Farmaceutici Italia Srl2024-09-09
Assessment of the Adjuvant Role of Dietary Supplementation of Antibiotic-tolerant Probiotics in Standard Therapy for the Eradication of Helicobacter Pylori Infection. (NCT06499649)IBSA Farmaceutici Italia Srl2024-07-03
Effect of Phaseolus Vulgaris L. Dry Extract on the Modulation of Weight and Metabolic Parameters (NCT06193577)IBSA Farmaceutici Italia Srl2023-11-08
Efficacy Evaluation of an ODF Iron Supplement Vs an Iron Supplement in Capsules in Subjects with Mild Anemia (NCT05989984)IBSA Farmaceutici Italia Srl2023-07-29
Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient (NCT05936346)IBSA Farmaceutici Italia Srl2023-07-17
Safety and Efficacy of Intralesional HiLow Hyaluronic Acid in the Treatment of Peyronie's Disease (PD) (NCT05871177)IBSA Farmaceutici Italia Srl2023-05-21
Cross-over Study to Evaluate the Rate and the Extent of Iron Absorption of an ODF Iron Supplement vs an Iron Supplement in Capsules (NCT05660200)IBSA Farmaceutici Italia Srl2022-11-25
Evaluation of Efficacy and Safety of HCC_45 for the Correction of Acne Scars of the Face (NCT05691049)IBSA Farmaceutici Italia Srl2022-11-24
Aesthetic Performance and Tolerance of an Injective Intradermal Treatment for the Skin Roughness and Laxity of Back of the Hands (NCT05590364)IBSA Farmaceutici Italia Srl2022-11-07

Track IBSA Farmaceutici Italia Srl automatically

Every clearance here is in the API, with alerts when new ones post.